Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Preferred Shares: 2013-2016

Historic Preferred Shares for Arrowhead Pharmaceuticals (ARWR) over the last 4 years, with Sep 2016 value amounting to $16.

  • Arrowhead Pharmaceuticals' Preferred Shares changed negligibly% to $16 in Q3 2016 from the same period last year, while for Sep 2016 it was $16, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $16 for FY2016, which is negligibly% changed negligibly from last year.
  • As of FY2016, Arrowhead Pharmaceuticals' Preferred Shares stood at $16, which was down 0.00% from $16 recorded in FY2015.
  • Arrowhead Pharmaceuticals' 5-year Preferred Shares high stood at $18 for FY2014, and its period low was $10 during FY2013.
  • Over the past 3 years, Arrowhead Pharmaceuticals' median Preferred Shares value was $16 (recorded in 2016), while the average stood at $16.67.
  • Per our database at Business Quant, Arrowhead Pharmaceuticals' Preferred Shares skyrocketed by 80.00% in 2014 and then declined by 11.11% in 2015.
  • Yearly analysis of 4 years shows Arrowhead Pharmaceuticals' Preferred Shares stood at $10 in 2013, then soared by 80.00% to $18 in 2014, then decreased by 11.11% to $16 in 2015, then remained steady at $16 in 2016.